Arteris, INC Form 4 insider transactions

Arteris, Inc. CEO Charles Janac sold 50,000 shares of common stock on February 3, 2025, at a weighted average price of $10.3295 per share, pursuant to a pre-arranged 10b5-1 trading plan.

Arteris director Saiyed Atiq Raza sold 2,776 shares of common stock at an average price of $12.3366 per share on January 6, 2025, under a pre-arranged 10b5-1 trading plan.

Paul Alpern, VP and General Counsel of Arteris Inc., sold 3,326 shares of common stock at an average price of $12.3484 per share, as part of a pre-arranged 10b5-1 trading plan.

Arteris Inc.'s Chief Operating Officer, Laurent R. Moll, sold 1,161 shares of common stock at $12.52 per share on January 6, 2025, under a pre-arranged 10b5-1 trading plan.

Arteris Inc.'s CFO, Nicholas B. Hawkins, sold 4,560 shares of common stock at an average price of $12.3394 per share on January 6, 2025, under a pre-arranged 10b5-1 trading plan.

Arteris Inc.'s CEO, Charles Janac, sold 8,432 shares of common stock at an average price of $12.3382 per share under a pre-arranged 10b5-1 trading plan and corrected a previous reporting error.

Director Joachim Kunkel acquired 1,514 shares of Arteris, Inc. common stock on January 5, 2025, as compensation in lieu of cash.

Director Antonio J. Viana acquired 2,040 shares of Arteris, Inc. common stock on January 5, 2025, as compensation in lieu of cash.

Wayne C. Cantwell, a director at Arteris, Inc., sold 10,000 shares of common stock over two days under a pre-arranged 10b5-1 trading plan.

Director Saiyed Atiq Raza sold 3,025 shares of Arteris, Inc. common stock at an average price of $10.1553 on January 2, 2025, under a pre-arranged 10b5-1 trading plan.

Arteris CEO, Charles Janac, sold shares to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.

Paul Alpern, VP and General Counsel at Arteris Inc., sold a portion of his common stock to cover tax liabilities arising from the vesting of restricted stock units.

Arteris CFO Nicholas Hawkins sold a total of 14,387 shares of common stock on January 2, 2025, to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.

Arteris Inc.'s Chief Operating Officer, Laurent R. Moll, sold a total of 39,831 shares of common stock in multiple transactions on January 2nd and 3rd, 2025, under a pre-arranged 10b5-1 trading plan.

Arteris CEO Charles Janac sold a total of 71,109 shares of common stock in two transactions on December 30 and 31, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris CEO Charles Janac sold a total of 116,325 shares of common stock over two days under a pre-arranged 10b5-1 trading plan.

Director Saiyed Atiq Raza sold 41,439 shares of Arteris, Inc. common stock at an average price of $10.3655, as part of a pre-arranged 10b5-1 trading plan.

Director Saiyed Atiq Raza sold a total of 27,083 shares of Arteris, Inc. common stock in two transactions on December 17 and 18, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris CEO Charles Janac sold a total of 26,801 shares of common stock in two transactions on December 17th and 18th, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris CEO Charles Janac sold a total of 65,509 shares of common stock in two transactions on December 13th and 16th, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris Inc. director Saiyed Atiq Raza sold a total of 68,249 shares of common stock in two transactions under a pre-arranged 10b5-1 trading plan.

Arteris director Saiyed Atiq Raza sold a total of 19,350 shares of common stock in two transactions on December 11 and 12, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris CEO Charles Janac sold a total of 20,256 shares of common stock on December 11th and 12th, 2024, under a pre-arranged 10b5-1 trading plan.

Director Wayne C. Cantwell of Arteris Inc. sold a total of 5,000 shares of common stock over two days under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s CFO, Nicholas B. Hawkins, sold 722 shares of common stock at $9.30 per share on December 5, 2024, under a pre-arranged 10b5-1 trading plan.

Director Isabelle F. Geday of Arteris, Inc. sold 15,550 shares of common stock at an average price of $9.0325 per share on December 4, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris Inc.'s VP and General Counsel, Paul L. Alpern, sold a total of 683 shares of common stock on December 3rd and 5th, 2024, to cover tax liabilities and under a pre-arranged trading plan.

Arteris Inc.'s Chief Operating Officer, Laurent R. Moll, sold shares to cover tax liabilities and under a pre-arranged trading plan.

Arteris CEO Charles Janac sold a total of 3,303 shares of common stock on December 3rd and 4th, 2024, to cover tax liabilities and under a pre-arranged trading plan.

Arteris Inc.'s CFO, Nicholas B. Hawkins, sold a total of 10,437 shares of common stock between December 2nd and December 4th, 2024, under a pre-arranged 10b5-1 trading plan.